Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
23.93
-0.48 (-1.97%)
At close: May 1, 2025, 4:00 PM
23.99
+0.06 (0.25%)
After-hours: May 1, 2025, 7:20 PM EDT
Pfizer Revenue
Pfizer had revenue of $13.72B in the quarter ending March 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 13.80% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+13.80%
P/S Ratio
2.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
135.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
PFE News
- 3 hours ago - The GLP-1 Saga Continues, And How - Seeking Alpha
- 15 hours ago - Dividend Harvesting Portfolio Week 217: $21,700 Allocated, $2,179.74 In Projected Dividends - Seeking Alpha
- 1 day ago - Pfizer's Q1 Update May Mark A Bottom In The Stock - Seeking Alpha
- 1 day ago - Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away - Business Insider
- 2 days ago - Pfizer could make ‘tremendous investments' in the US, but here's why it's choosing not to - Invezz
- 2 days ago - Pfizer Inc. (PFE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Pfizer's 7% Yield Makes It Look Like a Junk Bond—But Better - Barrons
- 2 days ago - Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D - CNBC